Severe bacteremia results in a loss of hepatic bacterial clearance

Alix Ashare1, Martha M Monick, Linda S Powers

  • 1Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa College of Medicine, 200 Hawkins Drive, C-33 GH, Iowa City, IA 52242, USA. alix-ashare@uiowa.edu

Abstract

Insights

Liver injury impairs bacterial clearance during sepsis, increasing mortality. Protecting hepatic bacterial clearance, potentially via caspase inhibitors or Kupffer cells, improves sepsis outcomes.

Area of Science:

  • Sepsis research
  • Hepatology
  • Immunology

Background:

  • Liver injury is suspected to impair bacterial clearance from the blood.
  • No previous studies investigated hepatic bacterial clearance during sepsis progression.

Purpose of the Study:

  • To test the hypothesis that liver injury during sepsis impairs hepatic bacterial clearance.
  • To determine the role of hepatic bacterial clearance in sepsis outcome.

Main Methods:

  • Induced mild and severe bacteremia in C57BL/6 mice using Pseudomonas aeruginosa.
  • Evaluated hepatic bacterial clearance, mortality rates, and the effects of caspase inhibitors and Kupffer cell ablation.

Main Results:

  • Mortality rates were 20% (mild bacteremia) and 60% (severe bacteremia).
  • Hepatic bacterial clearance was maintained in mild sepsis but lost in severe sepsis, correlating with increased bacteremia and mortality.
  • Caspase inhibition preserved clearance in severe sepsis; Kupffer cell ablation impaired clearance, worsening sepsis severity and outcomes.

Conclusions:

  • Hepatic bacterial clearance can be lost during sepsis, leading to uncontrolled bacteremia and increased mortality.
  • The liver's capacity to clear bacteria is a critical factor in determining sepsis outcomes.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...